Beam Therapeutics

IPO

Breaking new ground to advance science with the potential to change lives

Public · Cambridge, United States · Founded 2017 · $528.0M raised

Employees
201–500
Founded
2017
Business Model
B2B
Website
beamtx.com
Total Funding
$528.0M
Last Round
$100.0M Growth EquityFeb 2026
Rounds
4
Type
Public

About

Beam Therapeutics is a clinical-stage biotech company pioneering base editing technology to develop precision genetic medicines. Their platform uses proprietary base editors delivered via nonviral, electroporation, and viral modalities to correct disease-causing mutations in DNA. The company's pipeline targets serious diseases including sickle cell disease, phenylketonuria, and alpha-1 antitrypsin deficiency.

Summary

Beam Therapeutics is a Biotech company based in Cambridge, United States, founded in 2017. It has raised $528.0M in total across 4 rounds, most recently a $100.0M Growth Equity round in Feb 2026. Investors include F-Prime Capital, ARCH Venture Partners and Sixth Street.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Growth EquityGrowth EquityFeb 2026
$100.0M

Sign up to see all 5 rounds

Series A through Growth Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Beam Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/beam-therapeutics"><img src="https://indexed.vc/api/badge/company/beam-therapeutics" alt="Beam Therapeutics on Indexed.vc" width="260" height="76" /></a>